IL10 and graft versus host disease: Combined therapy with donor alloantigens and a probiotic; induced Tregs that conferred enduring protection against GVHD while preserving GVL activity and, similar to our results, this tolerogenic mechanism required IL-10 sufficient B cells in the recipients62.